+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ampio Pharmaceuticals Inc - logo

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

Small Molecules Contract Development and Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Small Molecules Contract Development and Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • December 2020
  • 314 Pages
  • Global
From
Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Sicca Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 110 Pages
  • Global
From
Ampion Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ampion Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 667 Pages
  • Global
From
C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020 - Product Thumbnail Image

C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 55 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H2 2020 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 3207 Pages
  • Global
From
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 49 Pages
  • Global
From
Bromodomain Testis Specific Protein - Pipeline Review, H2 2020 - Product Thumbnail Image

Bromodomain Testis Specific Protein - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Heparanase - Pipeline Review, H2 2020 - Product Thumbnail Image

Heparanase - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 58 Pages
  • Global
From
High Mobility Group Protein B1 - Pipeline Review, H2 2020 - Product Thumbnail Image

High Mobility Group Protein B1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 50 Pages
  • Global
From
Ampio Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Ampio Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Loading Indicator